Company profile: PGXIS Ltd

Pharmacogenomics. 2011 Sep;12(9):1253-6. doi: 10.2217/pgs.11.87.

Abstract

Pharmacogenomic Innovative Solutions Ltd (PGXIS) was established in 2007 by a group of pharmacogenomic (PGx) experts to make their expertise available to biotechnology and pharmaceutical companies. PGXIS has subsequently established a network of experts to broaden its access to relevant PGx knowledge and technologies. In addition, it has developed a novel multivariate analysis method called Taxonomy3 which is both a data integration tool and a targeting tool. Together with siRNA methodology from CytoPathfinder Inc., PGXIS now has an extensive range of diverse PGx methodologies focused on enhancing drug development.

MeSH terms

  • Biomarkers, Pharmacological
  • Clinical Trials as Topic
  • Drug Discovery / economics
  • Drug Discovery / ethics
  • Drug Industry / education
  • Drug Industry / ethics
  • Humans
  • Molecular Targeted Therapy
  • Pharmacogenetics / ethics
  • Pharmacogenetics / trends*
  • Precision Medicine*
  • Research / education*

Substances

  • Biomarkers, Pharmacological